The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells

Cited by (866)

Items 201–300 of 866

  1. NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
    Hani Alrefai, Khalid Muhammad, Ronald Rudolf, Duong Anh Thuy Pham, Stefan Klein‐Hessling, Amiya Kumar Patra, Andris Avots, Valesca Bukur, Uğur Şahin, Stefan Tenzer et al. · 2016 · Nature Communications
  2. Tumor accomplice: T cell exhaustion induced by chronic inflammation
    Liguang Fang, Kunjing Liu, Cun Liu, Xiaomin Wang, Wenzhe Ma, Wenhua Xu, Jibiao Wu, Changgang Sun · 2022 · Frontiers in Immunology
  3. Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion
    Laure Tillé, Daniela Cropp, Mélanie Charmoy, Patrick Reichenbach, Massimo Andreatta, Tania Wyss, Gabrielle Bodley, Isaac Crespo, Sina Nassiri, João Lourenço et al. · 2023 · Nature Immunology
  4. Modular pooled discovery of synthetic knockin sequences to program durable cell therapies
    Franziska Blaeschke, Yan Yi Chen, Ryan Apathy, Bence Dániel, Andy Y. Chen, Peixin Amy Chen, Katalin Sándor, Wenxi Zhang, Zhongmei Li, Cody T. Mowery et al. · 2023 · Cell
  5. Tick-TOX, it’s time for T cell exhaustion
    Thomas H. Mann, Susan M. Kaech · 2019 · Nature Immunology
  6. Exhausted T cells and epigenetic status
    Ziqing Zeng, Feng Wei, Xiubao Ren · 2020 · Cancer Biology and Medicine
  7. CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
    Leticia Laura Niborski, Paul Gueguen, Mengliang Ye, Allan Thiolat, Rodrigo Nalio Ramos, Pamela Caudana, Jordan Denizeau, Ludovic Colombeau, Raphaël Rodriguez, Christel Goudot et al. · 2022 · Nature Communications
  8. DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes
    Jeffrey D. Price, Chie Hotta-Iwamura, Yongge Zhao, Nicole Marie Beauchamp, Kristin V. Tarbell · 2015 · Diabetes
  9. The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
    H. Moffett, Adam N. Cartwright, Hye-Jung Kim, J. Godec, Jason W Pyrdol, Tarmo Äijö, G. Martinez, A. Rao, Jun Lu, T. Golub et al. · 2017 · Nature Immunology
  10. Dynamic Post-Transcriptional Events Governing CD8+ T Cell Homeostasis and Effector Function
    Fiamma Salerno, Martin Turner, Monika C. Wolkers · 2020 · Trends in Immunology
  11. Loss of core fucosylation enhances the anticancer activity of cytotoxic T lymphocytes by increasing PD‐1 degradation
    Nianzhu Zhang, Ming Li, Xing Xu, Yingshu Zhang, Yan‐Cheng Liu, Meng Zhao, Peng Li, Jun Chen, Tomohiko Fukuda, Jianguo Gu et al. · 2020 · European Journal of Immunology
  12. Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
    Kenji Ichiyama, Jia Long, Yusuke Kobayashi, Yuji Horita, Takeshi Kinoshita, Yamami Nakamura, Chizuko Kominami, Katia Georgopoulos, Shimon Sakaguchi · 2024 · Immunity
  13. Integration of Kinase and Calcium Signaling at the Level of Chromatin Underlies Inducible Gene Activation in T Cells
    Ruth Brignall, Pierre Cauchy, Sarah L. Bevington, Bethany Gorman, Angela Oliveira Pisco, James Bagnall, Christopher Boddington, William Rowe, Hazel England, Kevin Rich et al. · 2017 · The Journal of Immunology
  14. Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
    Valeria Barili, Paola Fisicaro, Barbara Montanini, Greta Acerbi, Anita Filippi, Giovanna Forleo, Chiara Romualdi, Manuela Ferracin, Francesca Guerrieri, Giuseppe Pedrazzi et al. · 2020 · Nature Communications
  15. Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation
    Frank A. Buquicchio, Raíssa Fonseca, Patrick Yan, Fangyi Wang, Maximilien Evrard, Andreas Obers, Jacob C. Gutierrez, Colin J. Raposo, Julia A. Belk, Bence Dániel et al. · 2024 · Immunity
  16. Unraveling exhaustion in adaptive and conventional NK cells
    Aimee Marie Merino, Hansol Kim, Jeffrey S. Miller, Frank M. Cichocki · 2020 · Journal of Leukocyte Biology
  17. Mechanisms of T cell exhaustion guiding next-generation immunotherapy
    Zebley, Caitlin C., Youngblood, Ben · 2022 · Trends in Cancer
  18. BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
    Mengjun Zhong, Rili Gao, Ruocong Zhao, Youxue Huang, Cunte Chen, Kehan Li, Xibao Yu, Dingrui Nie, Zheng Chen, Xin Liu et al. · 2022 · Cell Death and Disease
  19. Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells
    Luisa Bell, Alexander Lenhart, Andreas Rosenwald, Camelia Maria Monoranu, Friederike Berberich‐Siebelt · 2020 · Frontiers in Immunology
  20. Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective
    Negar Sadat Sherafat, Ali Keshavarz, Amirhossein Mardi, Amirmohammad Mohammadiara, Mojtaba Aghaei, Leili Aghebati Maleki, Mohammad Hossein Mohammadi · 2025 · Clinical and Experimental Medicine
  21. Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes
    Lledó-Delgado, Ana, Preston-Hurlburt, Paula, Currie, Sophia, Clark, Pamela, Linsley, Peter S., Long, S. Alice, Liu, Can, Koroleva, Galina, Martins, Andrew J., Tsang, John S. et al. · 2024 · Journal of Clinical Investigation
  22. Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol
    Nasser Gholijani, Marjan Gharagozloo, Fathollah Kalantar, Amin Ramezani, Zahra Amirghofran · 2015 · Advanced Pharmaceutical Bulletin
  23. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis
    Shi‐Ying Cai, Dongke Yu, Carol J. Soroka, Jing Wang, James Lorenzen Boyer · 2020 · Journal of Hepatology
  24. IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma
    Vikas Somani, Daoxiang Zhang, Paarth B. Dodhiawala, Varintra E. Lander, Xiuting Liu, Liang‐I Kang, Hung-Po Chen, Brett L. Knolhoff, Lin Li, Patrick M. Grierson et al. · 2022 · Gastroenterology
  25. Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
    Mehmet Emrah Selli, Jack H. Landmann, Marina Terekhova, John Lattin, Amanda D. Heard, Yu-Sung Hsu, Tien-Ching Chang, Jufang Chang, John M. Warrington, Helen Ha et al. · 2023 · Blood
  26. Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
    Yiran Wu, Yuchen Wu, Zhengyu Gao, Weixing Yu, Long Zhang, Fangfang Zhou · 2026 · Signal Transduction and Targeted Therapy
  27. Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells
    Christian H. Gabriel, Fridolin Groß, Martin Karl, Heike Stephanowitz, Anna Floriane Hennig, Melanie Weber, Stefanie Gryzik, Ivo Bachmann, Katharina Hecklau, Jürgen Wienands et al. · 2016 · Journal of Biological Chemistry
  28. TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies
    Simone A. Minnie, Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R.W. Legg, Melissa Comstock, Julie R. Boiko et al. · 2024 · Science Immunology
  29. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation
    Teresa Lozano, Lorea Villanueva, Maika Durántez, Marta Gorraiz, Marta Ruiz, Virginia Belsúe, José Ignacio Riezu‐Boj, Sandra Hervás‐Stubbs, Julen Oyarzábal, Hozefa S. Bandukwala et al. · 2015 · The Journal of Immunology
  30. IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation
    Xun Liu, Fei Li, Hongxia Niu, Lan Ma, Jianzhu Chen, Ying Zhang, Liang Peng, Chao Gan, Xingming Ma, Bingdong Zhu · 2019 · Frontiers in Immunology
  31. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength
    Thomas A.E. Elliot, Emma K. Jennings, David A.J. Lecky, Natasha Thawait, Adriana Flores‐Langarica, Alastair Copland, Kendle M. Maslowski, David Cameron Wraith, David Bending · 2021 · Immunity
  32. Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
    Taylor Leigh Wilson, Hyunjin Kim, Ching‐Heng Chou, Deanna M. Langfitt, Robert C. Mettelman, Anastasia A. Minervina, Emma Kaitlynn Allen, Jean‐Yves Métais, Mikhail V. Pogorelyy, Janice M. Riberdy et al. · 2022 · Cancer Discovery
  33. Exhausted CD8+ T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection
    Ioana Sandu, Dario Cerletti, Manfred Claassen, Annette Oxenius · 2020 · Nature Communications
  34. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance
    Mayura V. Wagle, Stephin J. Vervoort, Madison J. Kelly, Willem Van Der Byl, Timothy J. Peters, Ben P. Martin, Luciano Gastón Martelotto, Simone Nüssing, Kelly M. Ramsbottom, James Torpy et al. · 2021 · Nature Communications
  35. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
    Aditi Jain, Vikas Bhardwaj · 2021 · World Journal of Gastroenterology
  36. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes
    Abhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, Marit Martina Melssen, Itay Tirosh, Benjamin Izar, Tae‐Gyun Kim, Christopher J. Nirschl, K. Sanjana P. Devi, Walter C. Olson et al. · 2022 · Cancer Cell
  37. T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
    Xiaoxia Chi, Shahang Luo, Peng Ye, Wei‐Lun Hwang, Jong‐Ho Cha, Xiuwen Yan, Wenhao Yang · 2023 · Frontiers in Immunology
  38. Molecular Dissection of CD8 + T-Cell Dysfunction
    Chao Wang, Meromit Singer, Ana Carrizosa Anderson · 2017 · Trends in Immunology
  39. The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy
    Goran Micevic, Marcus Bosenberg, Qin Yan · 2022 · Clinical Cancer Research
  40. Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells
    Nicholas M. Provine, Rafael A. Larocca, Malika Aïd, Pablo Penaloza‐MacMaster, Alexander Badamchi-Zadeh, Erica N. Borducchi, Kathleen B. Yates, Peter Abbink, Marinela Kirilova, David Ng’ang’a et al. · 2016 · The Journal of Immunology
  41. Coordinating Cytoskeleton and Molecular Traffic in T Cell Migration, Activation, and Effector Functions
    Marta Mastrogiovanni, Marie Juzans, Andrés Alcover, Vincenzo Di Bartolo · 2020 · Frontiers in Cell and Developmental Biology
  42. The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
    Hongcheng Cheng, Kaili Ma, Lianjun Zhang, Guideng Li · 2021 · Cancer Letters
  43. Knowns and Unknowns about CAR-T Cell Dysfunction
    Aleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Aygul Rakhmatullina, Alexey Petukhov, Мифтахова Регина Рифкатовна, Albert Anatolyevich Rizvanov, Emil Bulatov · 2022 · Cancers
  44. SPP1 + TAM Regulates the Metastatic Colonization of CXCR4 + Metastasis‐Associated Tumor Cells by Remodeling the Lymph Node Microenvironment
    Liang Dong, Shujun Hu, Xin Li, Shiyao Pei, Liping Jin, Lining Zhang, Xiang Chen, Anjie Min, Mingzhu Yin · 2024 · Advanced Science
  45. Molecular Mechanisms Governing CD8 T Cell Differentiation and Checkpoint Inhibitor Response in Cancer
    Lisa Rausch, Axel Kallies · 2025 · Annual Review of Immunology
  46. Selective elimination of immunosuppressive T cells in patients with multiple myeloma
    Mohamed H.S. Awwad, Abdelrahman Mahmoud, Heiko Bruns, Hakim Echchannaoui, Katharina Kriegsmann, Raphael Lutz, Marc Steffen Raab, Uta Bertsch, Markus Munder, Anna Sophia Jauch et al. · 2021 · Leukemia
  47. A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
    Nikos Kourtis, Qingqing Wang, Bei Wang, Erin M. Oswald, Christina Adler, Samvitha Cherravuru, Evangelia Malahias, Lance Zhang, Jacquelynn Golubov, Qiaozhi Wei et al. · 2022 · Nature Cancer
  48. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
    Yuanyuan Wang, Tingxuan Gu, Xueli Tian, Wenwen Li, Ran Zhao, Wenqian Yang, Quanli Gao, Tiepeng Li, Jung‐Hyun Shim, Chengjuan Zhang et al. · 2021 · Frontiers in Immunology
  49. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance
    Yu Zhang, Rongbei Liu, Qian Cao, Ke-qi Fan, Ling-jie Huang, Jian-shuai Yu, Zhengjun Gao, Tao Huang, Jiang-yan Zhong, Xin-tao Mao et al. · 2019 · Journal of Clinical Investigation
  50. Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion
    Julia Busselaar, Sun Tian, Hans van Eenennaam, Jannie G. Borst · 2020 · Frontiers in Immunology
  51. Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy
    Giselle M. Boukhaled, Ramy Gadalla, Heidi J. Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang, Mengdi Guo, Ben X. Wang, Babak Noamani, Diana Gray et al. · 2022 · Nature Immunology
  52. Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment
    Qianting Guan, Meiwen Han, Qinghao Guo, Fangfei Yan, Ming Wang, Qin Ning, Dong Xi · 2023 · Frontiers in Immunology
  53. Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
    Yinghui Huang, Shin Foong Ngiow, Amy E. Baxter, Sasikanth Manne, Simone L. Park, Jennifer E. Wu, Omar Khan, Josephine Ruth Giles, E. John Wherry · 2025 · Science Immunology
  54. IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response
    Junjie Zhang, Hao Feng, Jun Zhao, Emily R. Feldman, Si–Yi Chen, Weiming Yuan, Canhua Huang, Omid Akbari, Scott A. Tibbetts, Pinghui Feng · 2016 · Cell Reports
  55. Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
    Zoe C. Schmiechen, Ingunn M. Stromnes · 2021 · Frontiers in Immunology
  56. Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
    Marie Marotel, Marine Villard, Annabelle Drouillard, Issam Tout, Laurie Besson, Omran Allatif, Marine Pujol, Yamila Rocca, Michelle Ainouze, Guillaume Roblot et al. · 2021 · eLife
  57. Regulation of activated T cell survival in rheumatic autoimmune diseases
    Florencia Rosetti, Iris Karina Madera-Salcedo, Noé Rodríguez‐Rodríguez, José Carlos Crispín · 2022 · Nature Reviews Rheumatology
  58. Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
    Roy, Dia, Gilmour, Cassandra, Patnaik, Sachin, Wang, Li Lily · 2023 · Frontiers in Immunology
  59. Epigenetic regulation of natural killer cell memory*
    Colleen M. Lau, Gabriela Maria Wiedemann, Joseph Chai-Yuen Sun · 2021 · Immunological Reviews
  60. Stem cell like memory T cells: A new paradigm in cancer immunotherapy
    Fengdi Wang, Fanjun Cheng, Zheng Fang · 2022 · Clinical Immunology
  61. Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy
    Anandaroop Mukhopadhyay, Jocelyn H. Wright, Shawna A. Shirley, David A. Canton, Christoph Burkart, Richard J. Connolly, Jean S. Campbell, Robert Hamilton Pierce · 2018 · Gene Therapy
  62. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
    Sergio Ayala‐Mar, Javier Donoso‐Quezada, José González‐Valdez · 2021 · Journal of Immunology Research
  63. Adenomatous Polyposis Coli Defines Treg Differentiation and Anti-inflammatory Function through Microtubule-Mediated NFAT Localization
    Sonia Agüera‐González, Oliver T. Burton, Elena Vázquez-Chávez, Céline Cuche, Floriane Herit, Jérôme Bouchet, Rémi Lasserre, Iratxe del Río‐Iñiguez, Vincenzo Di Bartolo, Andrés Alcover · 2017 · Cell Reports
  64. Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells
    Natsumi Maeda, Takumi Maruhashi, Daisuke Sugiura, Kenji Shimizu, Il‐mi Okazaki, Taku Okazaki · 2019 · Journal of Biological Chemistry
  65. T cell exhaustion is associated with antigen abundance and promotes transplant acceptance
    Dawei Zou, Yulin Dai, Xiaolong Zhang, Guohua Wang, Xiang Xiao, Peilin Jia, X.C. Li, Zhiyong Guo, Wenhao Chen · 2020 · American Journal of Transplantation
  66. Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
    Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, Min Hui Lim, Yinghui Huang, Michael S. Nelson, Arnab Chowdhury, Daniel B. Schmolze et al. · 2022 · JCI Insight
  67. TCF1–LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases
    Radomir Kratchmarov, Sarah Djeddi, Garrett S. Dunlap, Wenqin He, Xiaojiong Jia, Caitlin M. Burk, Tessa Ryan, Alanna McGill, Jessica Ravikoff Allegretti, Raghu P. Kataru et al. · 2024 · Nature Immunology
  68. T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies
    Valérie Janelle, Jean‐Sébastien Delisle · 2021 · Cancers
  69. Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer
    Lele Zhu, Xiaofei Zhou, Meidi Gu, Jiseong Kim, Yanchuan Li, Chun‐Jung Ko, Xiaoping Xie, Tianxiao Gao, Xuhong Cheng, Shao‐Cong Sun · 2022 · Nature Cell Biology
  70. Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells
    Jesús Corría-Osorio, Santiago J. Carmona, Evangelos Stefanidis, Massimo Andreatta, Yaquelin Ortiz-Miranda, Tania Muller, Ioanna A. Rota, Isaac Crespo, Bili Seijo, Wilson Castro et al. · 2023 · Nature Immunology
  71. NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
    Melanie Märklin, Jonas S. Heitmann, Alexander R. Fuchs, Felicia M. Truckenmüller, Michael F. Gutknecht, Stefanie Bugl, Sebastian Jonas Saur, Juliane Lazarus, Ursula Kohlhofer, Leticia Quintanilla‐Martínez et al. · 2017 · Nature Communications
  72. Early programming of CD8 + T cell response by the orphan nuclear receptor NR4A3
    Livia Odagiu, Salix Boulet, Dave Maurice De Sousa, Jean‐François Daudelin, Sandrine Nicolas, Nathalie Labrecque · 2020 · Proceedings of the National Academy of Sciences
  73. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK
    Michael P. Gallagher, James M. Conley, Pranitha Vangala, Manuel G. Garber, Andrea Reboldi, Leslie J. Berg · 2021 · Proceedings of the National Academy of Sciences
  74. Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis
    Tho Xuan Pham, Jisu Lee, Jiazhen Guan, Nunzia Caporarello, Jeffrey A. Meridew, Dakota L. Jones, Qi Tan, Steven Kenneth Huang, Daniel J. Tschumperlin, Giovanni Ligresti · 2022 · JCI Insight
  75. Increased DNA methylation, cellular senescence and premature epigenetic aging in guinea pigs and humans with tuberculosis
    Carly A. Bobak, Abhimanyu Abhimanyu, Harini Natarajan, Tanmay Gandhi, Sandra L. Grimm, Tomoki Nishiguchi, Kent J. Koster, Santiago Carrero Longlax, Qiniso Dlamini, Jacquiline Kahari et al. · 2022 · Aging
  76. Transcriptional and epigenetic regulation of T cell hyporesponsiveness
    Renata M. Pereira, Patrick G. Hogan, Anjana Rao, Gustavo Martínez · 2017 · Journal of Leukocyte Biology
  77. Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
    Jakrawadee Julamanee, Seitaro Terakura, Koji Umemura, Yoshitaka Adachi, Kotaro Miyao, Shingo Okuno, Erina Takagi, Toshiyasu Sakai, Daisuke Koyama, Tatsunori Goto et al. · 2021 · Molecular Therapy
  78. Extracellular vesicles derived from glioblastoma promote proliferation and migration of neural progenitor cells via PI3K-Akt pathway
    Jia-Bin Pan, Shiyang Sheng, Ling Ye, Xiaonan Xu, Yizhao Ma, Xuanran Feng, Lisha Qiu, Zhaohuan Fan, Yi Wang, Xiaohuan Xia et al. · 2022 · Cell Communication and Signaling
  79. Eomes transcription factor is required for the development and differentiation of invariant NKT cells
    Kanako Shimizu, Yusuke Sato, Masami Kawamura, Hiroshi Nakazato, Takashi Watanabe, Osamu Ohara, Shin‐ichiro Fujii · 2019 · Communications Biology
  80. Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
    Simone Nüssing, Joseph A. Trapani, Ian A. Parish · 2020 · Frontiers in Immunology
  81. Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
    Nancy M. Gonzalez, Dawei Zou, Andy Gu, Wenhao Chen · 2021 · Frontiers in Immunology
  82. Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
    Anna E. Brunell, Riitta Lahesmaa, Anu K Autio, Anil K. Thotakura · 2023 · Frontiers in Immunology
  83. Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming
    Paola Fisicaro, Carolina Boni, Valeria Barili, Diletta Laccabue, Carlo I. Ferrari · 2018 · Current Opinion in Virology
  84. Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
    Shannon M. Kahan, Allan J Zajac · 2019 · Viruses
  85. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression
    Abhimanyu Abhimanyu, Carlos Oscar Ontiveros, Rosa Selenia Guerra-Resendez, Tomoki Nishiguchi, Malik Ladki, Isaac B. Hilton, Larry S. Schlesinger, Andrew R. DiNardo · 2021 · Frontiers in Immunology
  86. Dynamic Adoption of Anergy by Antigen-Exhausted CD4 + T Cells
    Anne Trefzer, Pallavi Kadam, Shu-Hung Wang, Stefanie Pennavaria, Benedikt Lober, Batuhan Akçabozan, Jan Kranich, Thomas Brocker, Naoko Nakano, Martin Irmler et al. · 2020 · Cell Reports
  87. T cell-based cancer immunotherapy: opportunities and challenges
    Kaili Ma, Yingxi Xu, Hongcheng Cheng, Ke Tang, Jingwei Ma, Bo Huang · 2025 · 中国科学通报:英文版
  88. A Dual-Color Bioluminescence Reporter Mouse for Simultaneous in vivo Imaging of T Cell Localization and Function
    Jan Willem Kleinovink, Laura Mezzanotte, Giorgia Zambito, Marieke F. Fransen, Luis Javier Cruz, J. Sjef Verbeek, Alan B. Chan, FERRY A. OSSENDORP, Clemens W.G.M. Löwik · 2019 · Frontiers in Immunology
  89. Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure
    Mallory Paynich Murray, Isaac Engel, Grégory Seumois, Sara Herrera de la Mata, Sandy Lisette Rosales, Ashu Sethi, Ashmitaa Logandha Ramamoorthy Premlal, Goo‐Young Seo, Jason Greenbaum, Pandurangan Vijayanand et al. · 2021 · Nature Communications
  90. T cell exhaustion in human cancers
    Kuan Kang, Xin Lin, Pan Chen, Huai Liu, Feng Liu, Wei Xiong, Guiyuan Li, Mei Yi, Xiayu Li, Hui Wang et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  91. Early methionine availability attenuates T cell exhaustion
    Piyush Sharma, Ao Guo, Suresh Poudel, Emilio Boada-Romero, Katherine Verbist, Gustavo Palacios, Kalyan Immadisetty, Jinan Chen, Dalia Haydar, Ashutosh Mishra et al. · 2025 · Nature Immunology
  92. Equine arteritis virus long-term persistence is orchestrated by CD8+ T lymphocyte transcription factors, inhibitory receptors, and the CXCL16/CXCR6 axis
    Mariano Carossino, Pouya Dini, Ted Kalbfleisch, Alan Thomas Loynachan, Igor F. Canisso, R. Frank Cook, Peter J. Timoney, Udeni B. R. Balasuriya · 2019 · PLoS Pathogens
  93. Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
    Ornella Franzese, Grazia Graziani · 2022 · Cancers
  94. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming
    Jia‐Zhu Wu, Xiaojing Xu, Eun-Joon Lee, Austin Young Shull, Lirong Pei, Farrukh Tauseef Awan, Xiaoling Wang, Jeong-Hyeon Choi, Libin Deng, Hong‐Bo Xin et al. · 2016 · Oncotarget
  95. Common gamma chain cytokines and CD8 T cells in cancer
    Mitra Shourian, Jean‐Christophe Beltra, Benoîte Bourdin, Hélène Decaluwe · 2019 · Seminars in Immunology
  96. Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
    Jiatong Ding, Kangping Yang, Haonan Zhou, Ying-Feng Huang, Hui Li, Zhen Zong · 2023 · Frontiers in Immunology
  97. Immune checkpoint inhibitors for multiple myeloma immunotherapy
    Liu, Zhaoyun, Xu, Xintong, Liu, Hui, Zhao, Xianghong, Yang, Chun, Fu, Rong · 2023 · Experimental Hematology & Oncology
  98. The Interplay between T Cells and Cancer: The Basis of Immunotherapy
    Christina Chen, Xin Liu, Che‐Yu Chang, Helen Y. Wang, Rong‐Fu Wang · 2023 · Genes
  99. NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells
    Yibin Lin, Yifu Song, Yaochuan Zhang, Mengwu Shi, Ana Hou, Sheng Han · 2023 · Biomedicine & Pharmacotherapy
  100. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
    Megan Montoya, Marco Gallus, Su Myat Phyu, Jeffrey Haegelin, John de Groot, Hideho Okada · 2024 · Cells